1-4 of 4
Vivian G. Oehler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Project Confirm: Accelerated Drug Approvals for CML—Response

Kendra L. Sweet, Jorge E. Cortes, Jane F. Apperley, Mel Mann, Michael J. Mauro, Vivian G. Oehler, Cristina Ruiz, Charles A. Schiffer, Lori A. Ehrlich, Gulsum E. Pamuk, Joseph Wynne, Gautam U. Mehta, Olanrewaju O. Okusanya, R. Angelo de Claro, Marc R. Theoret, B. Douglas Smith, Kelly J. Norsworthy
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (1): 237–238.
https://doi.org/10.1158/1078-0432.CCR-23-3234
Published: 05 January 2024
View articletitled, Project Confirm: Accelerated Drug Approvals for CML—Response
Open the PDF for Project Confirm: Accelerated Drug Approvals for CML—Response in another window
Journal Articles

Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia

Kendra L. Sweet, Jorge E. Cortes, Jane F. Apperley, Mel Mann, Michael J. Mauro, Vivian G. Oehler, Cristina Ruiz, Charles A. Schiffer, Lori A. Ehrlich, Gulsum E. Pamuk, Joseph Wynne, Gautam U. Mehta, R. Angelo de Claro, Marc R. Theoret, B. Douglas Smith, Kelly J. Norsworthy
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (12): 2179–2183.
https://doi.org/10.1158/1078-0432.CCR-22-2628
Published: 13 June 2023
View articletitled, Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia
Open the PDF for Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia in another window
Journal Articles

Comprehensive Transcriptome Profiling of Cryptic CBFA2T3–GLIS2 Fusion–Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study

Jenny L. Smith, Rhonda E. Ries, Tiffany Hylkema, Todd A. Alonzo, Robert B. Gerbing, Marianne T. Santaguida, Lisa Eidenschink Brodersen, Laura Pardo, Carrie L. Cummings, Keith R. Loeb, Quy Le, Suzan Imren, Amanda R. Leonti, Alan S. Gamis, Richard Aplenc, E. Anders Kolb, Jason E. Farrar, Timothy J. Triche, Jr, Cu Nguyen, Daoud Meerzaman, Michael R. Loken, Vivian G. Oehler, Hamid Bolouri, Soheil Meshinchi
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (3): 726–737.
https://doi.org/10.1158/1078-0432.CCR-19-1800
Published: 03 February 2020
View articletitled, Comprehensive Transcriptome Profiling of Cryptic CBFA2T3–GLIS2 Fusion–Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study
Open the PDF for Comprehensive Transcriptome Profiling of Cryptic CBFA2T3–GLIS2 Fusion–Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study in another window
Includes: Supplementary data
Journal Articles

Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDS

Michael R. Savona, Daniel A. Pollyea, Wendy Stock, Vivian G. Oehler, Mark A. Schroeder, Jeffrey Lancet, James McCloskey, Hagop M. Kantarjian, Weidong Wendy Ma, M. Naveed Shaik, A. Douglas Laird, Mirjana Zeremski, Ashleigh O'Connell, Geoffrey Chan, Jorge E. Cortes
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (10): 2294–2303.
https://doi.org/10.1158/1078-0432.CCR-17-2824
Published: 14 May 2018
View articletitled, Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDS
Open the PDF for Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDS in another window
Includes: Supplementary data